A Single Ascending Dose, Open Label, Exploratory Study of OTL-038 for the Intra-operative Imaging of Folate Receptor Alpha Positive Ovarian Cancer

Trial Profile

A Single Ascending Dose, Open Label, Exploratory Study of OTL-038 for the Intra-operative Imaging of Folate Receptor Alpha Positive Ovarian Cancer

Recruiting
Phase of Trial: Phase II

Latest Information Update: 11 May 2016

At a glance

  • Drugs Folate-fluorescein isothiocyanate conjugate (Primary)
  • Indications Endometrial cancer; Ovarian cancer; Renal cancer
  • Focus Adverse reactions; Diagnostic use; Pharmacokinetics
  • Sponsors On Target Laboratories
  • Most Recent Events

    • 16 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top